Literature DB >> 19049976

ARF induces autophagy by virtue of interaction with Bcl-xl.

Julia Pimkina1, Olivier Humbey, Jack T Zilfou, Michal Jarnik, Maureen E Murphy.   

Abstract

The ARF tumor suppressor controls a well-described p53/Mdm2-dependent oncogenic stress checkpoint. In addition, ARF has recently been shown to localize to mitochondria, and to induce autophagy; however, this has never before been demonstrated for endogenous ARF, and the molecular basis for this activity of ARF has not been elucidated. Using an unbiased mass spectrometry-based approach, we show that mitochondrial ARF interacts with the Bcl2 family member Bcl-xl, which normally protects cells from autophagy by inhibiting the Beclin-1/Vps34 complex, which is essential for autophagy. We find that increased expression of ARF decreases Beclin-1/Bcl-xl complexes in cells, thereby providing a basis for ARF-induced autophagy. Our data also indicate that silencing p53 leads to high levels of ARF and increased autophagy, thereby providing a possible basis for the finding by others that p53 inhibits autophagy. The combined data support the premise that ARF induces autophagy in a p53-independent manner in part by virtue of its interaction with Bcl-xl.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19049976      PMCID: PMC2631963          DOI: 10.1074/jbc.M804705200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  The ARF tumor suppressor can promote the progression of some tumors.

Authors:  Olivier Humbey; Julia Pimkina; Jack T Zilfou; Michal Jarnik; Carmen Dominguez-Brauer; Darren J Burgess; Christine M Eischen; Maureen E Murphy
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

2.  Immunochemistry on ultrathin frozen sections.

Authors:  K T Tokuyasu
Journal:  Histochem J       Date:  1980-07

3.  Multiple domains of the mouse p19ARF tumor suppressor are involved in p53-independent apoptosis.

Authors:  Masaaki Matsuoka; Megumi Kurita; Haruka Sudo; Kiyohisa Mizumoto; Ikuo Nishimoto; Etsuro Ogata
Journal:  Biochem Biophys Res Commun       Date:  2003-02-21       Impact factor: 3.575

4.  Induction of autophagy and inhibition of tumorigenesis by beclin 1.

Authors:  X H Liang; S Jackson; M Seaman; K Brown; B Kempkes; H Hibshoosh; B Levine
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

5.  Analyses of Galpha-interacting protein and activator of G-protein-signaling-3 functions in macroautophagy.

Authors:  Sophie Pattingre; Anne Petiot; Patrice Codogno
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

6.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor.

Authors:  Zhenyu Yue; Shengkan Jin; Chingwen Yang; Arnold J Levine; Nathaniel Heintz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.

Authors:  Abhishek Datta; Alo Nag; Wei Pan; Nissim Hay; Andrei L Gartel; Oscar Colamonici; Yasuji Mori; Pradip Raychaudhuri
Journal:  J Biol Chem       Date:  2004-06-15       Impact factor: 5.157

8.  The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.

Authors:  Patrick Dumont; J I-Ju Leu; Anthony C Della Pietra; Donna L George; Maureen Murphy
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

9.  An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo.

Authors:  Michael T Hemann; Jordan S Fridman; Jack T Zilfou; Eva Hernando; Patrick J Paddison; Carlos Cordon-Cardo; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

10.  p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.

Authors:  Karen S Kelly-Spratt; Kay E Gurley; Yutaka Yasui; Christopher J Kemp
Journal:  PLoS Biol       Date:  2004-08-17       Impact factor: 8.029

View more
  48 in total

Review 1.  Autophagy and tumorigenesis.

Authors:  Nan Chen; Jayanta Debnath
Journal:  FEBS Lett       Date:  2009-12-24       Impact factor: 4.124

2.  BECN1 promotes radiation-induced G2/M arrest through regulation CDK1 activity: a potential role for autophagy in G2/M checkpoint.

Authors:  Ruixue Huang; Shanshan Gao; Yanqin Han; Huacheng Ning; Yao Zhou; Hua Guan; Xiaodan Liu; Shuang Yan; Ping-Kun Zhou
Journal:  Cell Death Discov       Date:  2020-08-05

3.  Interaction of the ARF tumor suppressor with cytosolic HSP70 contributes to its autophagy function.

Authors:  Julia Pimkina; Maureen E Murphy
Journal:  Cancer Biol Ther       Date:  2011-09-15       Impact factor: 4.742

Review 4.  An overview of stress response and hypometabolic strategies in Caenorhabditis elegans: conserved and contrasting signals with the mammalian system.

Authors:  Benjamin Lant; Kenneth B Storey
Journal:  Int J Biol Sci       Date:  2010-01-07       Impact factor: 6.580

Review 5.  Toll-like receptors in control of immunological autophagy.

Authors:  M A Delgado; V Deretic
Journal:  Cell Death Differ       Date:  2009-05-15       Impact factor: 15.828

Review 6.  Autophagy and tumorigenesis.

Authors:  Srirupa Roy; Jayanta Debnath
Journal:  Semin Immunopathol       Date:  2010-06-30       Impact factor: 9.623

Review 7.  Cytoplasmic functions of the tumour suppressor p53.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

Review 8.  Autophagy in cellular growth control.

Authors:  Richard C Wang; Beth Levine
Journal:  FEBS Lett       Date:  2010-01-22       Impact factor: 4.124

9.  The Beclin 1 interactome.

Authors:  Congcong He; Beth Levine
Journal:  Curr Opin Cell Biol       Date:  2010-01-22       Impact factor: 8.382

10.  The role of autophagy in tumour development and cancer therapy.

Authors:  Mathias T Rosenfeldt; Kevin M Ryan
Journal:  Expert Rev Mol Med       Date:  2009-12-02       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.